Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy.
about
Antibody recognition of a unique tumor-specific glycopeptide antigen5-Aza-2'-deoxycytidine increases sialyl Lewis X on MUC1 by stimulating β-galactoside:α2,3-sialyltransferase 6 gene.Glycoproteome study in myocardial lesions serum by integrated mass spectrometry approach: preliminary insights.Metabolic labeling of sialic acids in living animals with alkynyl sugars.Localization of O-glycosylation sites on glycopeptide fragments from lactation-associated MUC1. All putative sites within the tandem repeat are glycosylation targets in vivo.Click Triazoles for Bioconjugation.Dynamic Sialylation in Transforming Growth Factor-β (TGF-β)-induced Epithelial to Mesenchymal Transition.Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells.Glycoproteomics enabled by tagging sialic acid- or galactose-terminated glycansDevelopment of a novel bi-specific monoclonal antibody approach for tumour targeting.HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometriumCarbohydrate vaccines: developing sweet solutions to sticky situations?Stage-specific embryonic antigen-4 as a potential therapeutic target in glioblastoma multiforme and other cancers.Development of fucosyltransferase and fucosidase inhibitors.The Cosmc connection to the Tn antigen in cancer.Preparation of alginate/chitosan microcapsules and enteric coated granules of mistletoe lectin.Immunohistochemical detection of the MUC1 gene product in human cancers grown in scid mice.Synthesis of glycosylated β³-homo-threonine conjugates for mucin-like glycopeptide antigen analogues.One-pot multi-enzyme (OPME) chemoenzymatic synthesis of sialyl-Tn-MUC1 and sialyl-T-MUC1 glycopeptides containing natural or non-natural sialic acid.Convergent synthesis of MUC1 glycopeptides via serine ligation.Cancer specific Mucin-1 glycoforms are expressed on multiple myeloma.Engineering O-Glycosylation Points in Non-extended Peptides: Implications for the Molecular Recognition of Short Tumor-Associated Glycopeptides
P2860
Q27661722-58630859-B25E-4FCB-A705-E2BAC07FA831Q30499157-CA315A28-9441-4612-9600-8475DEDEE5C0Q33523250-F4A9E71A-E12B-447A-A826-57294057069BQ33845967-60E1F154-5F4C-43A1-A8BE-2B349BE62800Q34440632-4134CD8D-23F3-4E6B-9C7D-3444B800F807Q34571184-5697BCB7-7B59-4EA4-B795-DE1AD00D41E9Q35583066-FD490DEB-0BEC-45A9-9F96-8150C385A599Q35669639-449C5D03-BE25-4F86-9D2C-264A36651CF6Q36491781-4E671306-4666-4145-9665-00D27AB77C1BQ36619778-F1E0DD67-BF5D-4E39-8077-613BE79D18B8Q36621588-2922E746-90DE-42FE-9E6D-9AD19466EB46Q37426039-0486A1D7-1728-441E-B5E4-DFEC80224B61Q37599805-1E31C079-993C-4A60-8AA5-6649235E07BFQ38099178-3D46704F-65BC-45B5-A610-16A7C8B7998FQ38197051-E5FFC605-0FD9-4BED-8111-686FE7357753Q40589048-1FACB9D2-9AE8-4F5E-90BF-4145B03DDAC8Q41075775-9B118CF8-5DE0-4D61-B11F-586084043766Q41136648-E63AD4F4-7D72-455B-A2C3-4518917A7B8DQ43076252-F4AE1160-71E7-4787-B34B-ED95E501609EQ50940828-3C4946F2-6B20-44DC-B587-7C96C6C2E419Q53596391-7DEF3D04-4744-4375-A638-5E8041129CEFQ57515385-A3706A7F-CAEF-400D-B7EF-220527CFD453
P2860
Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Exploiting altered glycosylati ...... nges in diagnosis and therapy.
@en
type
label
Exploiting altered glycosylati ...... nges in diagnosis and therapy.
@en
prefLabel
Exploiting altered glycosylati ...... nges in diagnosis and therapy.
@en
P1476
Exploiting altered glycosylati ...... nges in diagnosis and therapy.
@en
P2093
Epenetos AA
Taylor-Papadimitriou J
P304
P356
10.1016/0167-7799(94)90121-X
P577
1994-06-01T00:00:00Z